Tradestie Institutional Equity Comparison Engine

TLX vs CGON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin while CGON counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, TLX trades at N/M Forward P/E with 6.2% operating margin (+22.3% YoY revenue) versus CGON at N/M Forward P/E and -4293.5% operating margin (-3.7% YoY). In options structure, TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CGON sits in CONSOLIDATION (85th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
TLX N/M vs CGON N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin 6.2% vs -4293.5% ยท YoY +22.3% vs -3.7%
Momentum & Technical Winner CGON
1Y -5.5% vs +125.0% ยท 52W Pos 40% vs 84%
Options & Structure Winner CGON
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (85th %ile IV)
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.98
-2.65% 1D
Market Cap $3.2B
1M Return -15.95%
1Y Return -5.52%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 64.0 Fund 62.0 Flow 50.0 Mom 60.0
CGON NASDAQ
CG Oncology, Inc. Common stock
Biological Products, (No Disgnostic Substances)
$84.94
+14.17% 1D
Market Cap $6.3B
1M Return +41.93%
1Y Return +124.96%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 15.0 Fund 44.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TLX -5.52% CGON +124.96% Spread: +130.48 pp (CGON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TLX TTM Op. Margin: 6.2% CGON TTM Op. Margin: -4293.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TLX vs CGON. Trailing 12-month operating profitability (TLX 6.2% vs CGON -4293.5%) and valuation multiples (TLX N/M vs CGON N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TLX (7) vs CGON (2)
Institutional Metric TLX CGON Criterion Row Winner
Market Capitalization Scale $3.2B $6.3B Larger Scale CGON
Trailing P/E Ratio Valuation 93.6x N/M Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +22.3% -3.7% Higher Growth TLX
Operating Margin (TTM) Profitability 6.2% -4293.5% Higher Margin TLX
Net Profit Margin Profitability 3.8% 0.0% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency 7.4% -28.3% Higher ROE TLX
52-Week Range Position Momentum 40% ($6โ€“$13) 84% ($37โ€“$94) Stronger Trend CGON
Beta / 30D Volatility Risk Regime 0.84ฮฒ ยท 62% Vol 0.75ฮฒ ยท 89% Vol Lower Realized Risk TLX
Unified Institutional Score Composite Signal 46.4 / 100 (HOLD) 45.0 / 100 (HOLD) Higher Composite TLX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TLX vs CGON Buy Guide
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CGON CONSOLIDATION
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 85th %ile
IV Regime Extreme (>80th %ile)
Live CGON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TLX nor CGON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.